A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2006
10/11/2006	CN1278687C Pharmaceutical composition for regeneration of cirrhotic liver
10/11/2006	CN1278686C Flunarizine hydrochloride soft capsule and its preparation method
10/11/2006	CN1278685C Oral sustained releasing micropill of tuduranine and their preparation method
10/11/2006	CN1278684C Method for preparing levogyrate amlodipine of maleic acid and uses and pharmaceutical composition containing it
10/11/2006	CN1278683C Use of dipeptidyl peptidase IV inhibitor in preparing medicine for treating anxiety neurosis
10/11/2006	CN1278682C Nanometer preparation of natural vitamin E
10/11/2006	CN1278681C Adduct of topiramate and tramadol hydrochloride and uses thereof
10/11/2006	CN1278680C Medicinal composition for treating bleeding disease and its use
10/11/2006	CN1278679C Application of coniferyl ferulate in preparing anticancer medicine
10/11/2006	CN1278678C Pharmaceutical composition of fenofibrate with high biological utilizing rate and its preparation method
10/11/2006	CN1278677C Composition for improving lipid metabolism
10/11/2006	CN1278676C Curcumin injection and method for preparing the same
10/11/2006	CN1278674C Orally disintegrating tablet of throat clearing medicine and its preparation process
10/11/2006	CN1278672C Pharmaceutical composition for intramuscular injection containing loxoprofen
10/11/2006	CN1278610C Externally used preparation for household pet disinsection and sterilization
10/11/2006	CA2542209A1 Dietary supplements comprising creatine and lipoic acid useful for enhancing muscle building and athletic preformance
10/10/2006	US7119246 Applying fluid of polyalkylene carbonate, penetrating pores, and forming a film covering area; removal; drug delivery
10/10/2006	US7119229 Having anticancer, anti-proliferous and anti-inflammatory effects and immunosuppressive and muscle relaxing functions
10/10/2006	US7119217 group III compounds such as gallium tripalmitate, used for prophylaxis of bone and autoimmune disorders, as antiinflammatory or anticarcinogernic agents
10/10/2006	US7119214 dibenzofuranyl, dibenzothiophenyl or fluorenyl thioacetamides used for prophylaxis of sleep disorders
10/10/2006	US7119208 drugs that bind to and increases oxygen affinity of hemoglobin, and preventing polymerization and formation fibrous precipitates hemoglobin, used for treatment of sickle-cell disease
10/10/2006	US7119207 NK-1 receptor antagonists, (e.g., substance P receptor antagonists)
10/10/2006	US7119206 drugs such as 12-[4-(2-Piperidin-1-yl-ethoxy)-phenyl]-7,12-dihydro-benzo[a]anthracene-3,9-diol, used for prevention of bone and cardiovascular disorders, as hypotensive, thrombolytic and anticholesterol agents
10/10/2006	US7119205 Thienopyridones as AMPK activators for the treatment of diabetes and obesity
10/10/2006	US7119203 Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
10/10/2006	US7119201 Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors
10/10/2006	US7119200 Pyrazolopyrimidines as cyclin dependent kinase inhibitors
10/10/2006	US7119198 beta-aryl-alpha-oxysubstituted alkylcarboxylic acids, usch as Ethyl (E/Z)-3-[4-[2-(phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropenoate, used as antilipemic or hypoglycemic agents
10/10/2006	US7119196 Anxiolytic agents with reduced sedative and ataxic effects
10/10/2006	US7119195 Pharmaceutically acceptable starch
10/10/2006	US7119180 Halogenation with a diphenylhalosulfonimide, deblocking the protected hydroxyl group; optional esterification or addition salt formation
10/10/2006	US7119124 Pharmaceutical compositions containing plasma protein
10/10/2006	US7119123 Antimicrobially active 4-methyl-4-aryl-2-pentanols, their preparation and use
10/10/2006	US7119122 Compounds for the inhibition of nitric oxide synthase
10/10/2006	US7119121 3,3-diphenylpropylamines useful in therapy
10/10/2006	US7119120 A 2-benzenesulfonylamino-N-benzyl-benzamides for treating hyperphosphatemia, urogential disorders
10/10/2006	US7119119 Immunoregulatory compounds and derivatives and methods of treating diseases therewith
10/10/2006	US7119118 90-95% eicosapentaenoic acid (EPA) and < 5% of docosahexaenoic acid (DHA); treating psychiatric or central nervous disorders
10/10/2006	US7119117 Tocopherol enriched compositions and amelioration of inflammatory symptoms
10/10/2006	US7119116 Direct aminolysis of a carbamate ester or hydrolysis to an acid followed by coupling with an amine; analgesics, disorders of eating, nervous system, psychology, sleep, urogenital, respiratory and gastrointestinal systems; antiischemic, anticarcinogenic, antiinflammatory agents, antiallergens
10/10/2006	US7119115 For therapy of treating tumors or cancerous cells
10/10/2006	US7119114 Pyrazoloanthrone and derivatives thereof as JNK inhibitors and compositions and methods related thereto
10/10/2006	US7119113 optionally halogenated N-(trifluoromethyloxazol-2-yl)xanthene-9-carboxamides; treatment of neurological disorders such as Alzheimer's disease and dementia
10/10/2006	US7119112 Sulfonamides as potassium channel blockers
10/10/2006	US7119111 2-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of use
10/10/2006	US7119110 Method and composition for preventing or reducing the symptoms of insulin resistance syndrome
10/10/2006	US7119109 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase
10/10/2006	US7119108 Pyrazole derivatives as cannabinoid receptor antagonists
10/10/2006	US7119107 Pyridone derivatives
10/10/2006	US7119106 Pharmaceutical compositions of 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline
10/10/2006	US7119105 Methods for treating neurodegenerative disorders using aspartyl protease inhibitors
10/10/2006	US7119104 Alpha-(oxy-, sulfo- or amino-)[3-(imidazolyl, oxazolyl or thiazolyl)alkylene(indazolyl, benzisoxazolyl or benzisothiazolyl)]acetic acids, esters or alkali salts
10/10/2006	US7119103 β3-Adrenoreceptor agonists, agonist compositions and methods of using
10/10/2006	US7119102 3-amino-6-{4-[2-hydroxy-2-(substituted heteroaryl)ethylamino]-piperidin-1-yl}thieno[2,3-b]pyridine-2-carboxylic acid amides; reductive amination; I kappa B kinase inhibitors; autoimmune diseases; antiinflammatory and anticarcinogenic agents
10/10/2006	US7119100 4,5-epoxy-6-methoxy-6,14-ethylene-7-(1-hydroxy-1-methyl-3-(thiophen-2-yl)-propyl)-17-(methyl, cyclopropyl methyl, cyclobutyl methyl or allyl) morphinan-3-ol; analgesics; opium addiction
10/10/2006	US7119099 DNA replication that interfere with the E1-E2-DNA complex during initiation of DNA replication; 1-(hydroxy, oxo, or epoxy)-3-oxo-3'-benzaminocarbonyl-4'-(carboxy or carboxylate)-1,2,3-trihydroindene-2-spiro-2'-tetrahydrofuran derivatives
10/10/2006	US7119098 Antitumor agents; osteoporosis; antiarthritic agents; oral diseases
10/10/2006	US7119097 2-(4,6-dimethoxypyrimidin-2-yloxy)-3-methoxy-3,3-diphenylpropionic acid; formulations for oral, parenteral, or nasopharyngeal delivery; endothelin receptor antagonist
10/10/2006	US7119096 Anticancer agents
10/10/2006	US7119095 Pharmaceutically active compounds and methods of use thereof
10/10/2006	US7119094 Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascade
10/10/2006	US7119093 3-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition
10/10/2006	US7119092 Chemical compounds
10/10/2006	US7119091 Triazaspiro[5.5]undecane derivatives and pharmaceutical compositions comprising thereof, as an active ingredient
10/10/2006	US7119090 Anticancer agents; antiinflammatory agents; autoimmune diseases; rheumatic diseases, enzyme inhibitors
10/10/2006	US7119089 Phenothiazine kinesin inhibitors
10/10/2006	US7119088 A bi-heterocycle-4H-2,3,5,10b-tetraaza-benzo[e]azulene derivatives; for therapy of dysmenorrhoea, anxiety disorder, asthma, atherosclerosis, cardiac failure, cardiovascular disease, cataract, central nervous system disease, motion sickness, Raynaud's disease, rheumatoid arthritis; chemical synthesis
10/10/2006	US7119087 4-(oxazolopyridin-2-yl)-1,4-diazabicyclo-[3.2.2]nonane derivatives, preparation and therapeutic use thereof
10/10/2006	US7119086 Affinity and selectivity for arginine-vasopressin and/or ocytocin receptors; synthesis
10/10/2006	US7119085 Inhibit amyloid protein deposits
10/10/2006	US7119084 4-amino-6-cycloalkyloxy-7-substituted quinazolines; inhibition of signal transduction mediated by tyrosine kinases; antitumor agents, respiratory system and gastrointestinal disorders
10/10/2006	US7119083 novel 2-(azetidin-2-on-1-yl)alkanedioic acid esters and amides useful for treating disease states that are associated with and responsive to antagonism of a vasopressin V1a receptor in a mammal
10/10/2006	US7119082 11β-long-chain-substituted 19-nor-17α-pregna-1,3,5(10)-trien-17β-ols with a 21,16α-lactone ring
10/10/2006	US7119081 Also estrogen phosphonates, thiophosphonates, sulphonates, sulphonamides, and N-acylsulfamates
10/10/2006	US7119080 Boronic ester and acid compounds, synthesis and uses
10/10/2006	US7119079 delivery of topically active therapeutic agents such as mesalamine to the duodenal, jejunal or proximal small bowel
10/10/2006	US7119076 Administering macrolide antibiotic
10/10/2006	US7119075 a microbiocide and a bioenhancer; 4-((1,3-benzodioxol-6-yl)-1,3-butadien-1-yl)-N-carbonylpiperidine and 3',5-Dihydroxy flavone 7-O- beta -D-galacturonide-4'-O- beta -D-glucopyranoside; reduced antibiotic resistance
10/10/2006	US7119074 Treatment of cancers, tumors and malignancies using amphiphilic prodrugs
10/10/2006	US7119068 Methods of screening for compounds that modulate TAFIa activity, compounds, and methods of using the compounds
10/10/2006	US7119065 Metal complex-protein composite and oxidation catalyst
10/10/2006	US7119061 Dalbavancin compositions for treatment of bacterial infections
10/10/2006	US7119049 Oxathiinecarboxamides
10/10/2006	US7118890 Antibodies to vertebrate delta proteins and fragments
10/10/2006	US7118888 Gene expression vaccine
10/10/2006	US7118770 Plant extracts formed via steam distillation of essential oils
10/10/2006	US7118768 Medicaments for treating colics
10/10/2006	US7118766 Pharmaceutical composition and process for isolation of trans-tetracos-15-enoic acid and method of treatment for hepatotoxicity
10/10/2006	US7118765 Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
10/10/2006	US7118763 Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
10/10/2006	US7118762 Controlling, stabilization blood, glucose concentration
10/10/2006	US7118759 Menstrual tampons comprising cerulenin, triclosan, or hexachlorophene to inhibit production of toxic shock syndrome toxins by gram-positive bacteria
10/10/2006	US7118750 Modified TNF-alpha molecules, DNA encoding such and vaccines comprising such modified TNF-alpha and DNA
10/10/2006	US7118734 Non-aqueous liquid shampoo composition
10/10/2006	US7118730 Quinoline derivative as diagnostic probe for disease with tau protein accumulation
10/10/2006	CA2535742C Preparation of risperidone
10/10/2006	CA2481848C Active ingredient particles carrying clopidogrel or a salt thereof, their use and method of preparation
10/10/2006	CA2418778C Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
10/10/2006	CA2374154C Uses of derivatives of polyaminoacid as moisturizing agent, and cosmeticand pharmaceutical compositions containing them
10/10/2006	CA2356391C Transdermal drug delivery system

1 ... 4058 4059 4060 4061 4062 4063 4064 4065 4066 4067 4068 4069 4070 4071 4072 4073 4074 4075 4076 4077 4078 ... 7860